Hidetomo Kobayashi
- Molecular Biology
- Immunology
- Genetics
- Endocrinology top 5%
- Molecular Medicine top 5%
- Co-authors
- Keinosuke OkamotoHiroyasu YamanakaEizo TakahashiHidetoshi NittaTakahisa ImamuraSoshi SeikeHaruka OzakiHideaki Karaki
- Topics
- Aquaculture disease management and microbiota (14 papers)Venomous Animal Envenomation and Studies (10 papers)Vibrio bacteria research studies (6 papers)
- Partner nations
- JapanIndiaUnited States
In The Last Decade
Hidetomo Kobayashi
46 papers receiving 580 citations
Peers
Comparison fields: 5 of 104
- Molecular Biology 212
- Immunology 162
- Genetics 110
- Endocrinology 103
- Molecular Medicine 96
Countries citing papers authored by Hidetomo Kobayashi
This map shows the geographic impact of Hidetomo Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetomo Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetomo Kobayashi more than expected).
Fields of papers citing papers by Hidetomo Kobayashi
This network shows the impact of papers produced by Hidetomo Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetomo Kobayashi. The network helps show where Hidetomo Kobayashi may publish in the future.
Co-authorship network of co-authors of Hidetomo Kobayashi
This figure shows the co-authorship network connecting the top 25 collaborators of Hidetomo Kobayashi. A scholar is included among the top collaborators of Hidetomo Kobayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetomo Kobayashi. Hidetomo Kobayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 57 | |
| 4 | 6 | |
| 5 | 3 | |
| 6 | 7 | |
| 7 | 21 | |
| 8 | 1 | |
| 9 | 21 | |
| 10 | 5 | |
| 11 | 20 | |
| 12 | 15 | |
| 13 | 1 | |
| 14 | 5 | |
| 15 | 13 | |
| 16 | 30 | |
| 17 | 56 | |
| 18 | 2 | |
| 19 | Clinical summary of intravenous use of vancomycin hydrochloride for severe infection caused by methicillin-resistant Staphylococcus aureus | 7 |
| 20 | 8 |
About Hidetomo Kobayashi
Hidetomo Kobayashi is a scholar working on Endocrinology, Immunology and Biotechnology, having authored 46 papers that have together received 593 indexed citations. Recurring topics across this work include Aquaculture disease management and microbiota (14 papers), Venomous Animal Envenomation and Studies (10 papers) and Vibrio bacteria research studies (6 papers). The work is most often cited by research in Endocrinology (103 citations), Molecular Medicine (96 citations) and Microbiology (67 citations). Hidetomo Kobayashi has collaborated with scholars based in Japan, India and United States. Frequent co-authors include Keinosuke Okamoto, Hiroyasu Yamanaka, Eizo Takahashi, Hidetoshi Nitta, Takahisa Imamura, Soshi Seike, Haruka Ozaki, Hideaki Karaki, Nobuhiro Fusetani and Masaaki Kobayashi. Their work appears in journals such as Journal of Biological Chemistry, Journal of Neuroscience and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.